Market Tracker

09/22 6:05pm ET

Theravance Inc (NASDAQ:THRX)

18.03
Data as of Sep 22
 -0.69 / -3.69%
Today’s Change
17.75
Today|||52-Week Range
34.23
-37.22%
Year-to-Date
No recent news for Theravance Inc.

Today’s Trading

Previous close18.72
Today’s open18.68
Day’s range17.75 - 18.86
Volume658,981
Average volume (3 months)924,995
Market cap$2.2B
Dividend yield5.55%
Data as of 3:59pm ET, 09/22/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+40.12%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book6.98

Competitors

 Today’s
change
Today’s
% change
AVNRAvanir Pharmaceutica...+0.17+1.54%
WXWuXi Pharmatech (Cay...+0.57+1.67%
MNKDMannkind Corp-0.20-3.23%
IRWDIronwood Pharmaceuti...-0.33-2.62%
Data as of 4:03pm ET, 09/22/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts